| Our Innovation Pipeline:
The Next Generation of Breakthroughs
| Our Innovation Pipeline:
The Next Generation of Breakthroughs
We’re harnessing the power of deep-learning AI to enable retinal scans to detect more than just eye-related diseases. We’re aiming to offer unprecedented insights into overall health. Join us on this exciting journey as we push the boundaries of medical science and bring intelligent, accessible diagnostics to the world.
| Closing the Care Gap
4Front360
We are pioneering an autonomous version of our optical diagnostic breakthrough, Nsight360, which can be administered and reported without the supervision of a physician. We call this innovation 4Front360.
It currently has been administered successfully for more than 150,000 patients in South Asia, extending the reach of the benefit and, at the same time, adding dimension to the body of data sets that inform and validate the technique.
| Closing the Care Gap
4Front360
4Front360
We are pioneering an autonomous version of our optical diagnostic breakthrough, Nsight360, which can be administered and reported without the supervision of a physician. We call this innovation 4Front360.
It currently has been administered successfully for more than 150,000 patients in South Asia, extending the reach of the benefit and, at the same time, adding dimension to the body of data sets that inform and validate the technique.
Cardiovascular Risk Assessment
Cardiovascular Risk Assessment
Already we can see with confidence that evidence of cardiovascular risk is revealed in retinal scans. We are working to complete the application of our “Human + AI” knowledge engineering to diagnosis of cardiovascular risk.
Cardiovascular disease is one of the most notorious care gaps in healthcare, and even though it is one of the top five factors in mortality, cardiovascular risk has persisted with few diagnostic tools. The first symptom for most people is a heart attack. We intend to play a role in addressing this effectively and efficiently by making intelligent diagnostics more widely available.
The Windows to 270 Diseases
The Windows to 270 Diseases
In addition to sight-threatening conditions in the eye, retinal scans have emerged as an effective, non-invasive window into full-body health. We were invited recently to take part in a conference on this subject by risk experts VSP Vision.
As reported by VSP and by MATTER, an organized community of healthcare innovators, a comprehensive eye exam can provide valuable insights on more than 270 systemic and chronic diseases, such as heart disease, diabetes, and neurological diseases such as Alzheimer’s.
We are working to extend the known accuracy and affordability of our systems of intelligent diagnosis to increase the availability of this array of vital insights.
